Compact Proton System ProNova's compact, cost efficient proton therapy platform combines advanced imaging, multi axis positioning, superconducting magnets, and PET based treatment verification, offering a strong value proposition to mid size and larger cancer centers looking to expand proton therapy without costly facilities.

Global Market Expansion The drive to make proton therapy accessible worldwide opens sales opportunities with international hospitals, regional networks, and emerging markets. Emphasize lower capital and operating costs and energy efficiency. Leverage NPC 2026 activity to generate leads.

Financing & Partnerships Recent seed funding and investor engagement signal readiness to support customer pilots, financing models, and staged deployments. Target buyers with flexible procurement, including hospital systems and care networks seeking performance based contracts.

Strategic Alliances New CEO tied to Provision Healthcare and collaboration with HHTC positions ProNova to attract enterprise customers and co develop systems. Pursue co development deals and exclusive distribution within partner networks.

Tech Driven Differentiation Unique combination of compact design, high performance, and closed loop PET treatment verification positions ProNova against traditional proton therapy vendors. Highlight this to oncology departments prioritizing precision, patient outcomes, and operational efficiency.